Modulation of cisplatin sensitivity in human ovarian carcinoma A2780 and SKOV3 cell lines by sulforaphane

Bartkowiak, 1999, Comparative analysis of apoptosis in HL60 detected by annexin-V and fluorescein-diacetate, Cytometry, 37, 191, 10.1002/(SICI)1097-0320(19991101)37:3<191::AID-CYTO5>3.0.CO;2-U Burrell, 2013, Replication stress links structural and numerical cancer chromosomal instability, Nature, 494, 492, 10.1038/nature11935 Chou, 1984, Quantitative analysis of dose-effect relationships: the combined effects of multiple drugs or enzyme inhibitors, Adv. Enzyme Regul., 22, 27, 10.1016/0065-2571(84)90007-4 Chou, 2006, Theoretical basis experimental design , and computerized simulation of synergism and antagonism in drug combination studies, Pharmacol. Rev., 58, 621, 10.1124/pr.58.3.10 Duesberg, 2000, Explaining the high mutation rates of cancer cells to drug and multidrug resistance by chromosome reassortments that are catalyzed by aneuploidy, Proc. Natl. Acad. Sci. U. S. A., 97, 14295, 10.1073/pnas.97.26.14295 Duesberg, 2001, Origin of multidrug resistance in cells with and without multidrug resistance genes: chromosome reassortments catalyzed by aneuploidy, Proc. Natl. Acad. Sci. U. S. A., 98, 11283, 10.1073/pnas.201398998 Duraj, 2013, Proteasome inhibition leads to altered signaling in the proteome of cisplatin-resistant human ovarian carcinoma cell line, Neoplasma, 60, 627, 10.4149/neo_2013_081 Fikrova, 2013, Detection of DNA crosslinks in peripheral lymphocytes isolated from patients treated with platinum derivates using modified comet assay, Neoplasma, 60, 413, 10.4149/neo_2013_053 Fimognari, 2005, Micronucleus formation and induction of apoptosis by different isothiocyanates and a mixture of isothiocyanates in human lymphocyte cultures, Mutat. Res., 582, 1, 10.1016/j.mrgentox.2004.11.019 Garrido, 2008, Cisplatin-mediated impairment of mitochondrial DNA metabolism inversely correlates with glutathione levels, Biochem. J., 414, 93, 10.1042/BJ20071615 Hunakova, 2007, Expression of new prognostic markers peripheral-type benzodiazepine receptor and carbonic anhydrase IX, in human breast and ovarian carcinoma cell lines, Neoplasma, 54, 541 Huq, 2014, Combinations of platinums and selected phytochemicals as a means of overcoming resistance in ovarian cancer, Anticancer Res., 34, 541 Standing Commitee on Human Cytogenetic Nomenclature, 1995, 114 Lee, 2011, Chromosomal instability confers intrinsic multidrug resistance, Cancer Res., 71, 1858, 10.1158/0008-5472.CAN-10-3604 McClelland, 2009, Chromosomal instability: a composite phenotype that influences sensitivity to chemotherapy, Cell Cycle, 8, 3262, 10.4161/cc.8.20.9690 McGranahan, 2012, Cancer chromosomal instability: therapeutic and diagnostic challenges, EMBO Rep., 13, 528, 10.1038/embor.2012.61 Miller, 2013, Administration of the Nrf2-ARE activators sulforaphane and carnosic acid attenuates 4-hydroxy-2-nonenal-induced mitochondrial dysfunction ex vivo, Free Radic. Biol. Med., 57, 1, 10.1016/j.freeradbiomed.2012.12.011 Mosmann, 1983, Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays, J. Immunol. Methods, 65, 55, 10.1016/0022-1759(83)90303-4 Pappa, 2007, Biphasic modulation of cell proliferation by sulforaphane at physiologically relevant exposure times in a human colon cancer cell line, Mol. Nutr. Food Res., 51, 977, 10.1002/mnfr.200700115 Pfuhler, 1996, Detection of DNA-crosslinking agents with the alkaline comet assay, Environ. Mol. Mutagen., 27, 196, 10.1002/(SICI)1098-2280(1996)27:3<196::AID-EM4>3.0.CO;2-D Piberger, 2014, The broccoli-born isothiocyanate sulforaphane impairs nucleotide excision repair: XPA as one potential target, Arch. Toxicol., 88, 647 Safaei, 2005, Abnormal lysosomal trafficking and enhanced exosomal export of cisplatin in drug-resistant human ovarian carcinoma cells, Mol. Cancer Ther., 4, 1595, 10.1158/1535-7163.MCT-05-0102 Sampath, 2001, Design of new anticancer therapies targeting cell cycle checkpoint pathways, Curr. Opin. Oncol., 13, 484, 10.1097/00001622-200111000-00011 Siddik, 2003, Cisplatin: mode of cytotoxic action and molecular basis of resistance, Oncogene, 22, 7265, 10.1038/sj.onc.1206933 Singh, 1988, A simple technique for quantitation of low levels of DNA damage in individual cells, Exp. Cell Res., 175, 184, 10.1016/0014-4827(88)90265-0 Slamenova, 1997, Detection of MNNG-induced DNA lesions in mammalian cells; validation of comet assay against DNA unwinding technique alkaline elution of DNA and chromosomal aberrations, Mutat. Res., 383, 243, 10.1016/S0921-8777(97)00007-4 Steinmetz, 1996, Vegetables fruit and cancer prevention: a review, J. Am. Diet. Assoc., 96, 1027, 10.1016/S0002-8223(96)00273-8 Venitt, 2014, 217 Wernyj, 2004, Molecular mechanisms of platinum resistance: still searching for the Achilles’ heel, Drug Resist. Updat., 7, 227, 10.1016/j.drup.2004.08.002